Status:
COMPLETED
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
Lead Sponsor:
Pfizer
Conditions:
Pneumococcal Diseases
Eligibility:
All Genders
Brief Summary
The aim of this study is to specify the serotype distribution of Streptococcus pneumoniae that causes invasive diseases at children and adults in Turkey.
Detailed Description
Non-interventional observational study Descriptive analysis will be conducted.
Eligibility Criteria
Inclusion
- Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) of the adults of 18 years of age or older with children that are younger than 18 years old at these centers and laboratories will be defined.
Exclusion
- Isolation of any other microorganism than pneumococcus at the same sample.
Key Trial Info
Start Date :
January 4 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
922 Patients enrolled
Trial Details
Trial ID
NCT01810861
Start Date
January 4 2013
End Date
July 31 2019
Last Update
April 6 2023
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Dokuz Eylul University Medical Faculty, Department of Chest Diseases
Balçova, İzmir, Turkey (Türkiye), 35340
2
Ankara Yüksek İhtisas Eğitim ve Araştırma Hastanesi Kardiyoloji Kliniği
Ankara / Altındağ, Turkey, Turkey (Türkiye), 06230
3
Gaziantep Universitesi Tip Fakultesi Mikrobiyoloji
Gaziantep, Turkiye, Turkey (Türkiye)
4
Istanbul Universitesi Istanbul Tip Fakultesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali
Istanbul, Turkiye, Turkey (Türkiye)